Royale Glutathione 462mg 12/2026 expiry
US$ 24.37
intravenous glutathione pharmacokinetics half-life Terminal and the time required to reach steady-state Pharmacokinetics of Drugs Following IV
Description
14161463., doi:10.3390/e15041416
2016;78:P5
There was a positive trend in the Composite SLE Responder Index in the Intention-to-treat (ITT) cohort, and post-hoc analysis showed that the BILAG secondary endpoint was met for a number of subgroups dosing levels, including low or no steroids, seropositivity, and patients with 2 grade BILAG improvement
Lutgen V, Qualmann K, Resch J, Kong L, Choi S, Baker DA
Petrin D, Delgaty K, Bhatt R, Garber G
